News

Despite trailing the broader market over the past year, Cigna Group still enjoys a strongly bullish long-term outlook from ...
The Cigna Group (NYSE:CI) is one of the best defensive stocks to invest in according to analysts. Cigna shares cracked over ...
If you want to stay updated on the latest options trades for Cigna Group, Benzinga Pro gives you real-time options trades alerts.
In a report released today, Andrew Mok CFA from Barclays maintained a Buy rating on Cigna, with a price target of $354.00. The company’s shares closed yesterday at $267.38. Take advantage of TipRanks ...
In a report released today, Sarah James from Cantor Fitzgerald reiterated a Buy rating on Cigna, with a price target of $365.00. The company’s shares closed yesterday at $297.86. Take advantage of ...
Cigna's recent market performance paints a complex picture, dropping 5.18% despite mixed analyst ratings. Institutional ...
Cigna's recent stock performance has investors on edge. The healthcare giant saw its shares tumble by 5.84%. Strong ...
Cigna (CI) came out with quarterly earnings of $7.2 per share, beating the Zacks Consensus Estimate of $7.14 per share. This compares to earnings of $6.72 per share a year ago. These figures are ...
Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With over $250 billion in annual US healthcare distribution sales, the company supplies ...
Speculation over a potential Berkshire Hathaway stake, alongside big moves from notable institutional investors, has added to ...
Analysts have recently evaluated Cigna Group and provided 12-month price targets. The average target is $366.62, accompanied ...